NovaBay Pharmaceuticals
12 hedge funds and large institutions have $308K invested in NovaBay Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
72% less capital invested
Capital invested by funds: $1.1M → $308K (-$790K)
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$26.3K | |
| 2 | +$22.9K | |
| 3 | +$18.3K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.29K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.14K |
Top Sellers
| 1 | -$63K | |
| 2 | -$60.6K | |
| 3 | -$51.5K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$35K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$34K |